Shenzhen, China

Xiuting Xu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiuting Xu. Retrieved from https://idiyas.com/inventor/xiuting-xu-59p21ev8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiuting Xu - Innovator in Lipid Nanoparticle Formulations

Introduction

Xiuting Xu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of lipid nanoparticle formulations. His work focuses on innovative methods for delivering nucleic acids, such as mRNA, which are crucial for various therapeutic applications.

Latest Patents

Xiuting Xu holds a patent for "Lipids and lipid nanoparticle formulations." This patent relates to lipids and lipid nanoparticle formulations, as well as methods for using these formulations to deliver nucleic acids. His innovative approach has the potential to enhance the efficacy of mRNA delivery systems.

Career Highlights

Xiuting Xu is currently associated with Longuide Biopharma Corporation, where he continues to advance research in lipid formulations. His expertise in this area has positioned him as a key figure in the biopharmaceutical industry.

Collaborations

He collaborates with notable colleagues, including Longgui Zhang and Yuebao Zhang, who contribute to the innovative research environment at Longuide Biopharma Corporation.

Conclusion

Xiuting Xu's work in lipid nanoparticle formulations represents a significant advancement in the delivery of nucleic acids for therapeutic purposes. His contributions are paving the way for future innovations in biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…